Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 26,674 $ 29,653
Restricted deposit 241 23
Trade receivables, net   9
Other accounts receivable and prepaid expenses 393 543
Inventories 714 1,430
Total current assets 28,022 31,658
Non-current assets:    
Restricted deposit 57 188
Operating lease right-of-use assets 3,070 2,711
Property and equipment, net 2,789 2,966
Intangible assets, net 188 245
Total non-current assets 6,104 6,110
Total assets 34,126 37,768
Current liabilities:    
Trade payables 980 1,133
Operating lease liabilities 624 529
Accrued liabilities and other payables 1,647 1,443
Total current liabilities 3,251 3,105
Non-current liabilities:    
Operating lease liabilities 2,535 2,382
Total non-current liabilities 2,535 2,382
Total liabilities 5,786 5,487
Commitments and contingencies  
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2023 and , 2022; issued and outstanding: 11,452,672 and 11,186,481 ordinary shares as of December 31, 2023 and 2022, respectively 4,982 4,873
Additional paid in capital 121,068 118,099
Accumulated other comprehensive loss (969) (969)
Accumulated deficit (96,741) (89,722)
Total shareholders’ equity 28,340 32,281
Total liabilities and shareholders’ equity $ 34,126 $ 37,768